This study, utilizing bioinformatics and experimental validation, has demonstrated that STA may exert its anti-hepatocellular carcinoma effects through multiple targets and pathways, particularly by regulating STAT3 and FN1. Here, STAT3 is linked to hepatocellular carcinoma.